Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Preferred Stock Liabilities (2017)

Historic Preferred Stock Liabilities for Iterum Therapeutics (ITRM) over the last 1 years, with Q4 2017 value amounting to $57000.0.

  • Iterum Therapeutics' Preferred Stock Liabilities changed N/A to $57000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $57000.0, marking a year-over-year change of. This contributed to the annual value of $57000.0 for FY2017, which is N/A changed from last year.
  • Latest data reveals that Iterum Therapeutics reported Preferred Stock Liabilities of $57000.0 as of Q4 2017.
  • In the past 5 years, Iterum Therapeutics' Preferred Stock Liabilities ranged from a high of $57000.0 in Q4 2017 and a low of $57000.0 during Q4 2017